BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17382905)

  • 1. Truncated pStat5B is associated with the Idd4 locus in NOD mice.
    Davoodi-Semiromi A; McDuffie M; Litherland S; Clare-Salzler M
    Biochem Biophys Res Commun; 2007 May; 356(3):655-61. PubMed ID: 17382905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
    Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
    Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS).
    Cooper JC; Boustead JN; Yu CL
    Cell Signal; 2006 Jun; 18(6):851-60. PubMed ID: 16125365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The idd4 locus displays sex-specific epistatic effects on type 1 diabetes susceptibility in nonobese diabetic mice.
    Ivakine EA; Mortin-Toth SM; Gulban OM; Valova A; Canty A; Scott C; Danska JS
    Diabetes; 2006 Dec; 55(12):3611-9. PubMed ID: 17130511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of PAF-AH Ib1 in NOD mice: PAF-AH may not be a candidate gene of the diabetes susceptibility Idd4.1 locus.
    Mi QS; Zhou L; Grattan M; Wang ZZ; Sivilotti M; She JX; Delovitch TL
    Ann N Y Acad Sci; 2006 Oct; 1079():147-52. PubMed ID: 17130546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
    Zerif E; Maalem A; Gaudreau S; Guindi C; Ramzan M; Véroneau S; Gris D; Stankova J; Rola-Pleszczynski M; Mourad W; Dupuis G; Amrani A
    J Autoimmun; 2017 Jan; 76():63-74. PubMed ID: 27634616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of Stat5b confers protection against diabetes in the non-obese diabetic (NOD) mice via up-regulation of CD4(+)CD25(+) regulatory T cells.
    Jin Y; Purohit S; Chen X; Yi B; She JX
    Biochem Biophys Res Commun; 2012 Aug; 424(4):669-74. PubMed ID: 22789848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice.
    Nagayama Y; Horie I; Saitoh O; Nakahara M; Abiru N
    J Autoimmun; 2007; 29(2-3):195-202. PubMed ID: 17826032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction.
    Litherland SA; Grebe KM; Belkin NS; Paek E; Elf J; Atkinson M; Morel L; Clare-Salzler MJ; McDuffie M
    J Immunol; 2005 Oct; 175(7):4561-5. PubMed ID: 16177100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Crkl expression contributes to the defective DNA binding of Stat5b in nonobese diabetic mice.
    Laloraya M; Davoodi-Semiromi A; Kumar GP; McDuffie M; She JX
    Diabetes; 2006 Mar; 55(3):734-41. PubMed ID: 16505237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
    Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two genetic loci independently confer susceptibility to autoimmune gastritis.
    Ang DK; Brodnicki TC; Jordan MA; Wilson WE; Silveira P; Gliddon BL; Baxter AG; van Driel IR
    Int Immunol; 2007 Sep; 19(9):1135-44. PubMed ID: 17698560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idd1 and Idd3 are necessary but not sufficient for development of type 1 diabetes in NOD mouse.
    Ikegami H; Fujisawa T; Sakamoto T; Makino S; Ogihara T
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S85-90. PubMed ID: 15563987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
    Srinivasan S; Bolick DT; Lukashev D; Lappas C; Sitkovsky M; Lynch KR; Hedrick CC
    Diabetes; 2008 Feb; 57(2):484-93. PubMed ID: 18003758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant Stat5b with weaker DNA binding affinity defines a key defective pathway in nonobese diabetic mice.
    Davoodi-Semiromi A; Laloraya M; Kumar GP; Purohit S; Jha RK; She JX
    J Biol Chem; 2004 Mar; 279(12):11553-61. PubMed ID: 14701862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells.
    Mariño E; Batten M; Groom J; Walters S; Liuwantara D; Mackay F; Grey ST
    Diabetes; 2008 Feb; 57(2):395-404. PubMed ID: 18025414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.